Sage Therapeutics said on Monday that its board has unanimously rejected the takeover offer it received from Biogen. The ...
Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback